We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Gene Found that Controls Obesity and Sexual Behavior

By Biotechdaily staff writers
Posted on 31 Dec 2002
In a recent study, researchers working with a mouse "knock-out” model have found that the Nhlh2 gene appears to play a role in obesity, physical activity, and sex behavior. More...
The study was published in the December 2002 issue of Physiology and Behavior.

Mice that lack the Nhlh2 gene weigh up to 100 g or more, while most normal mice weigh 25 to 30 grams. The mice eat far past what should be the point of satiety and show little inclination to run on the exercise wheel. They also have smaller genital size and lower sperm counts than typical mice. In addition, the mutant mice show disinterest in mating when they share a cage with a receptive female.

"The gene is responsible for giving them the message, ‘You are full, so stop eating,' or ‘You need to increase your activity, so get some exercise,” explained senior author Deborah J. Good, a researcher at the University of Massachusetts (Amherst, USA ) "Without Nhlh2, the message is sent but can not be received on a molecular level, so their body weight continues to increase.”

"There are humans who have this mutation,” said Dr. Good. "If we understand the molecular mechanisms that deal with obesity, perhaps we will be able to develop pharmaceuticals for people whose enzyme activity is offset. Moreover, humans can be coached to increase their exercise levels and lower their food intake.”




Related Links:
University of Massachusetts

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
MR-proADM Test
B•R•A•H•M•S MR-proADM KRYPTOR test
Immunofluorescence Analyzer
IFA System
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Alzheimer’s pathology can start 15 to 20 years before symptoms, and validated tools that reach patients earlier help pave the way for earlier detection. (Image Credit: Adobe Stock)

Alzheimer’s Blood Test Becomes First FDA-Cleared Option for Adults as Young as 40

C2N Diagnostics’ PrecivityAD2 blood test was cleared by the U.S. Food and Drug Administration (FDA) on August 20, 2026, for adults as young as 40 who are experiencing signs of cognitive impairment, according... Read more

Pathology

view channel
Image: Adrenal gland tumor stained with hematoxylin and eosin (top) and CYP11B2 (bottom) (Photo courtesy of Christofer Juhlin)

Simple Immunohistochemical Size Ratio Improves Classification of Primary Aldosteronism

Primary aldosteronism is a common but underdiagnosed cause of hypertension, in which excess aldosterone promotes salt retention and raises blood pressure. Identifying the dominant source of hormone overproduction... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.